MVR CANCON

There is no doubt that the science of oncology is on the threshold of a significant change. Newer concepts like immunotherapy and cancer glycemics has entered the everyday lexicon of therapeutics. Systemic effects of High precision radiotherapy is being better understood. Robotics is improving the therapeutic ratio of surgeries. Metabolic imaging and Cancer genomics are cutting open new pathways. Artificial intelligence is bringing in new paradigms by breaking down big data and guiding research, drug manufacturing and even decision making. To keep ourselves up to date about the various advancements happening in different streams has become a significant challenge.